Grave's Orbitopathy -Setting up an Orbital MDT and the Role of the Maxillofacial Surgeon

Background: Grave's Orbitopathy (GO) presents major clinical and therapeutic challenges. Clinically significant GO develops in 50% of patients with Grave's, with 3-5% being severe. The management pathway is based on the guidelines from the European Group on Grave's Orbitopathy (EUGOGO). In our unit, patients undergo multidisciplinary management with input from Endocrinology, Ophthalmology, Orthoptics, Radiology, ENT and in symptomatic cases Oral and Maxillofacial surgery, when orbital decompression is indicated.

from OroFacial via a.sfakia on Inoreader http://bit.ly/2Lvwpf9